Literature DB >> 19682689

Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages.

Xuyang Feng1, Yingmei Zhang, Ruifen Xu, Xin Xie, Ling Tao, Haokao Gao, Yan Gao, Zheng He, Haichang Wang.   

Abstract

Natural IgM antibodies against oxidized low-density lipoprotein (oxLDL) can inhibit the binding of oxLDL to macrophages and bacterial infection may deteriorate the pathogenesis of atherosclerosis. However, little is known about the molecular mechanisms underlying the action of bacterial lipopolysaccharide (LPS) in the binding of oxLDL to macrophages, contributing to the formation of foam macrophages. In this study, human monocytes-derived macrophages were cultured and incubated with purified human anti-oxLDL IgM antibodies (HAO-IgM), lipopolysaccharide (LPS) and oxLDL. The HAO-IgM were found specifically inhibited the binding of CuoxLDL to naïve macrophages but failed to inhibit the binding of CuoxLDL to LPS-activated macrophages and promoted the formation of CuoxLDL-mediated foam macrophages. Furthermore, the HAO-IgM F(ab')(2) or pre-incubation with unrelated IgM inhibited the binding of HAO-IgM/CuoxLDL complex to LPS-activated macrophages, suggesting that Fcalpha/mu receptor (Fcamr) may be responsible for the binding of HAO-IgM/CuoxLDL complex to LPS-activated macrophages. Indeed, LPS up-regulated the expression of Fcamr in macrophages in a dose- and time-dependent manner, which was diminished by treatment with anti-TLR4. In addition, LPS induced the phosphorylation of p38MAPK and translocation of NF-kappaB p65, contributing to the up-regulated expression of Fcamr in macrophages as treatment with specific inhibitor for p38MAPK (SB203580) or NF-kappaB (PDTC) attenuated the up-regulation of Fcalpha/mu receptor expression induced by LPS in macrophages. Inhibition of p38MAPK and NF-kappaB decreased the foam cells formation increased by Fcamr expression. These data demonstrated that LPS, through the TLR4 receptor, activated the p38MAPK and NF-kappaB pathways and up-regulate the expression of Fcamr in human macrophages, which promotes the binding of IgM/CuoxLDL complex to macrophages and the formation of foam cells. Therefore, our findings provide a new explanation why bacterial infection deteriorates the pathogenesis of atherosclerosis. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682689     DOI: 10.1016/j.atherosclerosis.2009.07.035

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  12 in total

1.  Lipopolysaccharide-induced proliferation of the vasa vasorum in a rabbit model of atherosclerosis as evaluated by contrast-enhanced ultrasound imaging and histology.

Authors:  Jinwei Tian; Sining Hu; Xue Han; Nana Dong; Huai Yu; Yanli Sun; Bo Yu
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

2.  Cationic peptide mR18L with lipid lowering properties inhibits LPS-induced systemic and liver inflammation in rats.

Authors:  Oleg F Sharifov; Gaurav Nayyar; Vladimir V Ternovoy; Vinod K Mishra; Silvio H Litovsky; Mayakonda N Palgunachari; David W Garber; G M Anantharamaiah; Himanshu Gupta
Journal:  Biochem Biophys Res Commun       Date:  2013-06-17       Impact factor: 3.575

3.  Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells.

Authors:  Vineesh V Raveendran; Xiaoyu Tan; Matthew E Sweeney; Beth Levant; Joyce Slusser; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Immunology       Date:  2011-01-24       Impact factor: 7.397

4.  Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4.

Authors:  Rui Liu; Yong He; Bo Li; Jun Liu; Yingang Ren; Wei Han; Xing Wang; Lihua Zhang
Journal:  Mol Cells       Date:  2012-06-12       Impact factor: 5.034

5.  IgM-Dependent Phagocytosis in Microglia Is Mediated by Complement Receptor 3, Not Fcα/μ Receptor.

Authors:  Jonathan R Weinstein; Yi Quan; Josiah F Hanson; Lucrezia Colonna; Michael Iorga; Shin-ichiro Honda; Kazuko Shibuya; Akira Shibuya; Keith B Elkon; Thomas Möller
Journal:  J Immunol       Date:  2015-10-23       Impact factor: 5.422

6.  Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress.

Authors:  Lei Gu; Wenli Bai; Sha Li; Yuqing Zhang; Yi Han; Yue Gu; Guoliang Meng; Liping Xie; Jing Wang; Yujiao Xiao; Liyang Shan; Suming Zhou; Lei Wei; Albert Ferro; Yong Ji
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

7.  SIRPα on Mouse B1 Cells Restricts Lymphoid Tissue Migration and Natural Antibody Production.

Authors:  Katka Franke; Saravanan Y Pillai; Mark Hoogenboezem; Marion J J Gijbels; Hanke L Matlung; Judy Geissler; Hugo Olsman; Chantal Pottgens; Patrick J van Gorp; Maria Ozsvar-Kozma; Yasuyuki Saito; Takashi Matozaki; Taco W Kuijpers; Rudi W Hendriks; Georg Kraal; Christoph J Binder; Menno P J de Winther; Timo K van den Berg
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

8.  Lipopolysaccharide promotes lipid accumulation in human adventitial fibroblasts via TLR4-NF-κB pathway.

Authors:  Jun Wang; Yanfang Si; Chen Wu; Lu Sun; Yudong Ma; Aili Ge; Baomin Li
Journal:  Lipids Health Dis       Date:  2012-10-17       Impact factor: 3.876

9.  Protective Roles of Natural IgM Antibodies.

Authors:  Caroline Grönwall; Jaya Vas; Gregg J Silverman
Journal:  Front Immunol       Date:  2012-04-04       Impact factor: 7.561

10.  mTOR signal transduction pathways contribute to TN-C FNIII A1 overexpression by mechanical stress in osteosarcoma cells.

Authors:  Lianhe Zheng; Dianzhong Zhang; Yunfei Zhang; Yanhua Wen; Yucai Wang
Journal:  Mol Cells       Date:  2014-02-19       Impact factor: 5.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.